Helen Siobhan Marshall

Summary

Affiliation: University of Adelaide
Country: Australia

Publications

  1. ncbi Uptake of varicella vaccine--a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation
    Helen Marshall
    Department of Paediatrics, Women s and Children s Hospital, 72 King William Road, North Adelaide, SA 5006, Australia
    Vaccine 23:5389-97. 2005
  2. ncbi A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years
    H Marshall
    Department of Paediatrics, Children s Youth and Women s Health Service and University of Adelaide, SA, Australia
    Vaccine 24:6120-8. 2006
  3. ncbi Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children
    Helen Siobhan Marshall
    University Department of Paediatrics, Women s and Children s Hospital, 72 King William Rd, North Adelaide 5006, South Australia, Australia
    Pediatrics 118:1501-9. 2006
  4. ncbi A cross-sectional survey to assess community attitudes to introduction of Human papillomavirus vaccine
    Helen Marshall
    Department of Paediatrics, Women s and Children s Hospital, School of Population Health and Clinical Practice, University of Adelaide, South Australia
    Aust N Z J Public Health 31:235-42. 2007
  5. ncbi A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults
    Helen S Marshall
    Vaccinology and Immunology Research Trials Unit, Women s and Children s Hospital and School of Paediatrics and Reproductive Health, University of Adelaide, North Adelaide, South Australia 5006, Australia
    Vaccine 31:1569-75. 2013
  6. ncbi Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial
    Helen S Marshall
    Vaccinology and Immunology Research Trials Unit, Women s and Children s Hospital and School of Paediatrics and Reproductive Health, University of Adelaide, North Adelaide, South Australia
    Pediatr Infect Dis J 31:1061-8. 2012
  7. ncbi Awareness, anxiety, compliance: community perceptions and response to the threat and reality of an influenza pandemic
    Helen Marshall
    Vacciniology and Immunology Research Trials Unit, Women s and Children s Hospital, Adelaide, Australia
    Am J Infect Control 40:270-2. 2012
  8. ncbi Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years
    Helen Marshall
    University of Adelaide, Adelaide, South Australia, Australia
    Vaccine 28:4411-5. 2010
  9. ncbi Pandemic influenza and community preparedness
    Helen Marshall
    Paediatric Trials Unit, Women s and Children s Hospital, 72 King William Rd, North Adelaide, South Australia
    Am J Public Health 99:S365-71. 2009
  10. ncbi Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine
    Helen Marshall
    Department of Paediatrics, Women s and Children s Hospital, North Adelaide, SA, Australia
    J Paediatr Child Health 45:297-303. 2009

Detail Information

Publications11

  1. ncbi Uptake of varicella vaccine--a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation
    Helen Marshall
    Department of Paediatrics, Women s and Children s Hospital, 72 King William Road, North Adelaide, SA 5006, Australia
    Vaccine 23:5389-97. 2005
    ..One year after inclusion of varicella vaccine in the Australian Standard Vaccination Schedule there is evidence of incomplete coverage in children in South Australia due to absence of government funding for vaccine provision...
  2. ncbi A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years
    H Marshall
    Department of Paediatrics, Children s Youth and Women s Health Service and University of Adelaide, SA, Australia
    Vaccine 24:6120-8. 2006
    ..This combined DTPa-IPV vaccine has a similar reactogenicity profile to DTPa, is immunogenic when given as a booster dose at 4-6 years of age, and has no impact on the immunogenicity of a co-administered second dose of MMR vaccine...
  3. ncbi Ultrasound examination of extensive limb swelling reactions after diphtheria-tetanus-acellular pertussis or reduced-antigen content diphtheria-tetanus-acellular pertussis immunization in preschool-aged children
    Helen Siobhan Marshall
    University Department of Paediatrics, Women s and Children s Hospital, 72 King William Rd, North Adelaide 5006, South Australia, Australia
    Pediatrics 118:1501-9. 2006
    ....
  4. ncbi A cross-sectional survey to assess community attitudes to introduction of Human papillomavirus vaccine
    Helen Marshall
    Department of Paediatrics, Women s and Children s Hospital, School of Population Health and Clinical Practice, University of Adelaide, South Australia
    Aust N Z J Public Health 31:235-42. 2007
    ..The aim of this study was to assess community attitudes to the introduction of HPV vaccine in the State of South Australia...
  5. ncbi A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults
    Helen S Marshall
    Vaccinology and Immunology Research Trials Unit, Women s and Children s Hospital and School of Paediatrics and Reproductive Health, University of Adelaide, North Adelaide, South Australia 5006, Australia
    Vaccine 31:1569-75. 2013
    ..A bivalent rLP2086 vaccine based on two factor H-binding proteins (fHBPs) has been developed to provide broad protection against MnB disease-causing strains...
  6. ncbi Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial
    Helen S Marshall
    Vaccinology and Immunology Research Trials Unit, Women s and Children s Hospital and School of Paediatrics and Reproductive Health, University of Adelaide, North Adelaide, South Australia
    Pediatr Infect Dis J 31:1061-8. 2012
    ..A bivalent, recombinant, factor H-binding protein (rLP2086) vaccine was developed to protect against invasive Neisseria meningitidis serogroup B (MnB) in children and adolescents...
  7. ncbi Awareness, anxiety, compliance: community perceptions and response to the threat and reality of an influenza pandemic
    Helen Marshall
    Vacciniology and Immunology Research Trials Unit, Women s and Children s Hospital, Adelaide, Australia
    Am J Infect Control 40:270-2. 2012
    ..Reported seasonal influenza vaccine uptake increased from 51.7% in 2007 to 61.4% in 2009, but there was more interest in receiving pandemic vaccine in 2007 (87.5%) than in 2009 (57%)...
  8. ncbi Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years
    Helen Marshall
    University of Adelaide, Adelaide, South Australia, Australia
    Vaccine 28:4411-5. 2010
    ..All subjects mounted a vigorous immune response to the challenge indicating the presence of immunological memory to HBV...
  9. ncbi Pandemic influenza and community preparedness
    Helen Marshall
    Paediatric Trials Unit, Women s and Children s Hospital, 72 King William Rd, North Adelaide, South Australia
    Am J Public Health 99:S365-71. 2009
    ..We aimed to examine community knowledge about and attitudes toward the threat of pandemic influenza and assess the community acceptability of strategies to reduce its effect...
  10. ncbi Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine
    Helen Marshall
    Department of Paediatrics, Women s and Children s Hospital, North Adelaide, SA, Australia
    J Paediatr Child Health 45:297-303. 2009
    ..The aim of this study was to examine immunisation practice when a vaccine is recommended but not funded by Government...
  11. ncbi Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic
    Helen Marshall
    School of Paediatrics and Reproductive Health, University of Adelaide and Paediatric Trials Unit, Women s and Children s Hospital, Children, Youth and Women s Health Service, 72 King William Road, North Adelaide SA 5006, Australia
    Int J Infect Dis 14:e41-9. 2010
    ..The aim of this study was to evaluate the safety and immunogenicity of DTPa-HBV and Hib vaccines given mixed or separately to 360 healthy infants at 2, 4, and 6 months of age...